[1]
Wahiduzzaman, M., Yasmin, A., Shahriar Hossain, M., Dhar, R. and Haider, M.M. 2025. Efficacy and safety of empagliflozin (SGLT2 inhibitor) in Bangladeshi patients with type 2 diabetes mellitus. International Journal of Research in Medical Sciences. 13, 12 (Nov. 2025), 5150–5154. DOI:https://doi.org/10.18203/2320-6012.ijrms20253934.